Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers

标题
Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
作者
关键词
NSCLC, Doxorubicin resistance, MRP1, P-gp, Hypoxia, HIF-1α
出版物
CELLULAR ONCOLOGY
Volume 39, Issue 5, Pages 411-433
出版商
Springer Nature
发表日期
2016-06-15
DOI
10.1007/s13402-016-0285-5

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search